查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1664229

不孕治疗服务的全球市场:手艺，各类服务，不孕原因，供应商，各地区，机会，预测，2018年～2032年

Fertility Services Market Assessment, By Procedure, By Service, By Cause of Infertility, By Provider, By Region, Opportunities and Forecast, 2018-2032F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 237 Pages | 商品交期: 3-5个工作天内

价格

全球生育治疗服务市场规模预计将从 2024 年的 393.1 亿美元增长到 2032 年的 778.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.92%。不孕症患者数量的增加、有利政策和举措的出台、对不孕不育治疗的认识和接受度的提高、以及对采用新技术的日益重视是推动市场扩张的一些关键因素。

此外，世界各地的医疗机构不断努力加强提供先进的不孕症治疗服务，也推动了市场的成长。各国正在加大对最先进设施的投资，以提供个人化治疗，满足日益增长的生育治疗需求。例如，2024 年 10 月，Burjeel Holdings 在其旗舰设施 Burjeel Medical City (BMC) 开设了 Trust 生育诊所。该诊所为处于不同人生阶段的女性提供全面的不孕症治疗服务以及全面、整体的医疗保健服务。该诊所配备了人工智慧（AI）驱动的胚胎选择等先进技术，确保改善治疗效果。预计此类技术的出现不仅可以改善中东的医疗旅游业，还可以为市场提供有利可图的成长机会。

人口减少的国家正在推出各种政策和措施来支持人口成长。东京计划从 2025 年 4 月起实施四天週末制，以增加工作场所的灵活性，让人们兼顾工作和家庭责任。采取这些措施是为了扭转人口危机并提高日本的出生率。日本的出生率预计在2024年首次跌破70万人。预计四天週末制度将使人们能够专心抚养孩子，而不会影响他们的职业发展。预计这些措施将鼓励人们专注于计划生育，并为市场提供有利的成长机会。

按按按本报告提供全球不孕治疗服务市场相关调查，提供市场概要，以及手艺，各类服务，不孕原因，供应商，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 全球不孕治疗服务市场预测，2018年～2032年

  • 市场规模的分析与预测
  • 市场占有率分析与预测
  • 市场地图分析，2024年
    • 按手艺
    • 各类服务
    • 按不孕原因
    • 按供应商
    • 各地区

第5章 北美的不孕治疗服务市场预测，2018年～2032年

第6章 欧洲的不孕治疗服务市场预测，2018年～2032年

第7章 亚太地区的不孕治疗服务市场预测，2018年～2032年

第8章 南美的不孕治疗服务市场预测，2018年～2032年

第9章 中东·非洲的不孕治疗服务市场预测，2018年～2032年

第10章 需求供给分析

第11章 价值链分析

第12章 波特的五力分析

第13章 大环境分析

第14章 价格分析

第15章 市场动态

第16章 市场趋势与发展

第17章 专利的形势

第18章 案例研究

第19章 竞争情形

  • 前五名市场领导的竞争矩阵
  • 前五名参与企业的SWOT分析
  • 前10名主要企业的形势
    • IVIRMA Global SL
    • Apollo Hospitals Group
    • Genea Pty Limited
    • Monash IVF Group
    • CRGH City
    • Virtus Health Group
    • OvaScience, Inc.
    • Weill Cornell Medicine
    • Progyny, Inc.
    • Carolinas Fertility Institute

第20章 策略性建议

第21章 关于调查公司·免责声明

Product Code: MX12776

Global fertility services market is projected to witness a CAGR of 8.92% during the forecast period 2025-2032, growing from USD 39.31 billion in 2024 to USD 77.86 billion in 2032. The rising cases of infertility, the introduction of favorable policies and initiatives, increasing awareness and acceptance of fertility treatments, and growing emphasis on introducing new technologies are some of the major factors supporting the market's expansion.

The growing efforts of healthcare organizations to bolster the availability of advanced fertility services across the globe are also propelling the market's growth. Countries are increasingly investing in state-of-the-art facilities to provide personalized treatments and address the rising requirement for fertility treatments. For instance, in October 2024, Burjeel Holdings launched the Trust Fertility Clinic at their flagship facility, Burjeel Medical City (BMC), to support patients suffering from fertility issues by providing them with personalized and compassionate care. The clinic offers a comprehensive range of fertility services along with integrated and holistic healthcare services for women at different stages of life. The clinic is equipped with advanced technologies such as artificial intelligence (AI)- driven embryo selection, ensuring enhanced treatment outcomes. The availability of such technologies is expected to provide lucrative growth opportunities for the market as well as improve medical tourism in the Middle East.

Countries with declining population growth are introducing various policies and initiatives to support population growth. The Tokyo Metropolitan Government plans on implementing a four-day workweek starting in April 2025, to improve workplace flexibility and allow the population to balance family responsibilities. Such measures are being introduced to reverse the population crisis and improve the country's birth rate. The number of births in Japan fell under 700,000 for the first time in 2024. The four-day workweek policy is expected to allow the population to focus on raising a family without having to compromise on career growth. Such measures are expected to encourage the population to focus on family planning and provide lucrative growth opportunities for the market.

Rising Government Initiatives Support Market Expansion

The introduction of supportive government policies and initiatives is significantly driving the growth of the market as it aids in improving affordability, accessibility, and awareness about the different fertility treatments available. Various governments are investing significantly in ensuring the availability of fertility services for a broader population group and proposing new tax credits to cover the costs of the treatment. For instance, in October 2024, the government of Ontario added USD 150 million to the Ontario Fertility Program to bolster access to fertility treatments over the course of the next two years. The additional funding is going to support the expansion of fertility clinics, ensuring reduced waiting periods in community centers and hospitals. The program will also include more clinics, providing more options to the patient population and increasing the ease of access to key fertility services. The government also proposed a new tax credit that would cover up to 25% of all eligible expenses, including travel for treatment and diagnostic testing, fertility medications, and IVF cycles. Such efforts are expected to bolster the demand for different fertility services and provide lucrative growth opportunities for the market.

Technological Advancements Drive Market Growth

The growing efforts of leading market players to ensure the availability of advanced technologies is one of the major drivers of the global fertility services market. Innovations such as minimally invasive egg retrieval, along with the integration of genetic screening and personalized treatment plans, are increasing patient acceptance and adoption and improving treatment outcomes. Hospitals and clinics across the globe are also ensuring the availability of novel technologies to enhance patient comfort and convenience. For instance, in February 2025, Corniche Hospital successfully performed a minimally invasive laparoscopic procedure for collecting and freezing eggs. The successful completion of the procedure is going to ensure that women who are unable to rely on traditional fertility preservation services can receive effective fertility preservation solutions. The efficient and safe nature of laparoscopic egg retrieval is also ensuring that women facing various social and medical challenges also have access to fertility services.

Rapid advancements in cryopreservation techniques also support the market's expansion by allowing a broader population group to preserve their genetic material for future utilization. Such advancements are augmenting the efficiency of fertility services and allowing hospitals and clinics to attract more patients, thus bolstering the market's growth.

Fertility Clinics Account for Significant Share of the Market

Fertility clinics account for a significant share of the market as they specialize in identifying the cause of infertility and providing suitable treatment options and supportive services. These clinics are usually run by reproductive endocrinologists with training in reproductive medicine and offer a wide range of services such as semen analysis, genetic screening, hormone testing, in-vitro fertilization (IVF), tubal ligation reversal, and egg freezing. These clinics also provide personalized treatments tailored to the specific requirements of the patient population.

Additionally, the growing efforts to bolster the availability of fertility services in underserved locations are also supporting the segment's expansion. In February 2025, Wellnest Fertility Inc. opened a Wellnest Fertility Clinic in Utah, United States. The state-of-the-art clinic offers comprehensive fertility solutions and provides personalized treatment plans and cutting-edge embryo monitoring technology, removing geographical barriers and allowing patients to receive high-quality fertility care. The introduction of continuous embryo monitoring technology gives embryologists various necessary insights, ultimately improving patient outcomes. The increasing availability of such facilities and services by fertility clinics across the globe is expected to bolster patient confidence in fertility services and treatment, providing lucrative growth opportunities for the market.

North America Region Holds Major Market Share

The rising requirement for advanced reproductive technologies can be attributed to increasing cases of infertility, rising awareness about the various treatment options available, reduced stigma about fertility services, and the introduction of supportive government policies and initiatives. Due to the presence of the required infrastructure, advanced technologies such as in-vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI), intrauterine insemination (IUI), and in-vitro fertilization without intracytoplasmic sperm injection (IVF without ICSI) are also easily available in the region. Such services offer high success rates, increasing confidence among the patient population, thus boosting the market's demand.

Additionally, growing efforts to expand fertility centers in the region support the market's expansion. For instance, in February 2025, Reproductive Partners Fertility Center- San Diego announced the expansion of their fertility care team to meet the growing demand for fertility services in the region. Through this expansion, the fertility center aims to provide a wide range of treatments for recurrent miscarriages, unexplained infertility, and diminished ovarian reserve. Such expansions showcase the rising requirement for fertility services and growing emphasis on the provision of high-quality care for patients.

Future Market Scenario (2025-2032F)

As per the global fertility services market analysis, the market is expected to grow significantly over the forecast period due to rising government initiatives to boost population growth, technological advancements, and increasing infertility rates in various regions. Various countries are introducing fertility-friendly policies, including financial assistance programs and insurance coverage for treatment procedures.

As more and more patients seek non-invasive treatments due to physical discomfort associated with fertility procedures, the demand for minimally invasive fertility treatments is expected to rise significantly over the coming years.

Factors such as increasing investments in fertility research, evolving societal attitudes towards fertility treatment, and the growing popularity of medical tourism are expected to support the market's expansion.

Rapid advancements in cryopreservation techniques due to increasing requirement for donation and storage of biological materials are expected to bolster the accessibility of fertility treatments for couples suffering from infertility. The World Health Organization (WHO) estimates that 1 in 6 adults across the globe experience infertility during their lifetime.

Key Players Landscape and Outlook

The leading players across the globe are focusing on expanding their presence and ensuring the availability of advanced services for the patient population. In order to do so, they are actively engaging in mergers and acquisitions along with partnerships with other fertility service providers. For instance, in October 2024, Ivy Fertility Services, LLC acquired Northern California Fertility Medical Center. This acquisition aligns with the global trend of consolidation in the fertility services sector, allowing larger networks to offer a broad range of services and innovative treatments. The companies are also going to expand their unified presence, making it easier for patients to access various fertility services and treatment options.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Fertility Services Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Procedure
      • 4.2.1.1. In-vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
      • 4.2.1.2. Intrauterine Insemination (IUI)
      • 4.2.1.3. In-vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
      • 4.2.1.4. Surrogacy
      • 4.2.1.5. Others
    • 4.2.2. By Service
      • 4.2.2.1. Fresh Non-Donor
      • 4.2.2.2. Frozen Non-Donor
      • 4.2.2.3. Egg and Embryo Banking
      • 4.2.2.4. Fresh Donor
      • 4.2.2.5. Frozen Donor
    • 4.2.3. By Cause of Infertility
      • 4.2.3.1. Male Infertility
      • 4.2.3.2. Female Infertility
    • 4.2.4. By Provider
      • 4.2.4.1. Fertility Clinics
      • 4.2.4.2. Hospitals
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Procedure
    • 4.3.2. By Service
    • 4.3.3. By Cause of Infertility
    • 4.3.4. By Provider
    • 4.3.5. By Region

5. North America Fertility Services Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Procedure
      • 5.2.1.1. In-vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
      • 5.2.1.2. Intrauterine Insemination (IUI)
      • 5.2.1.3. In-vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
      • 5.2.1.4. Surrogacy
      • 5.2.1.5. Others
    • 5.2.2. By Service
      • 5.2.2.1. Fresh Non-Donor
      • 5.2.2.2. Frozen Non-Donor
      • 5.2.2.3. Egg and Embryo Banking
      • 5.2.2.4. Fresh Donor
      • 5.2.2.5. Frozen Donor
    • 5.2.3. By Cause of Infertility
      • 5.2.3.1. Male Infertility
      • 5.2.3.2. Female Infertility
    • 5.2.4. By Provider
      • 5.2.4.1. Fertility Clinics
      • 5.2.4.2. Hospitals
      • 5.2.4.3. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Fertility Services Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Procedure
          • 5.3.1.2.1.1. In-vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
          • 5.3.1.2.1.2. Intrauterine Insemination (IUI)
          • 5.3.1.2.1.3. In-vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
          • 5.3.1.2.1.4. Surrogacy
          • 5.3.1.2.1.5. Others
        • 5.3.1.2.2. By Service
          • 5.3.1.2.2.1. Fresh Non-Donor
          • 5.3.1.2.2.2. Frozen Non-Donor
          • 5.3.1.2.2.3. Egg and Embryo Banking
          • 5.3.1.2.2.4. Fresh Donor
          • 5.3.1.2.2.5. Frozen Donor
        • 5.3.1.2.3. By Cause of Infertility
          • 5.3.1.2.3.1. Male Infertility
          • 5.3.1.2.3.2. Female Infertility
        • 5.3.1.2.4. By Provider
          • 5.3.1.2.4.1. Fertility Clinics
          • 5.3.1.2.4.2. Hospitals
          • 5.3.1.2.4.3. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Fertility Services Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Fertility Services Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Fertility Services Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Fertility Services Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. IVIRMA Global SL
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 19.3.2. Apollo Hospitals Group
    • 19.3.3. Genea Pty Limited
    • 19.3.4. Monash IVF Group
    • 19.3.5. CRGH City
    • 19.3.6. Virtus Health Group
    • 19.3.7. OvaScience, Inc.
    • 19.3.8. Weill Cornell Medicine
    • 19.3.9. Progyny, Inc.
    • 19.3.10. Carolinas Fertility Institute

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 3. Global Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 4. Global Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 5. Global Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 6. Global Fertility Services Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 9. North America Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 10. North America Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 11. North America Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 12. North America Fertility Services Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 15. United States Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 16. United States Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 17. United States Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 18. Canada Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 20. Canada Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 21. Canada Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 22. Canada Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 23. Mexico Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 25. Mexico Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 26. Mexico Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 27. Mexico Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 28. Europe Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 30. Europe Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 31. Europe Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 32. Europe Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 33. Europe Fertility Services Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 36. Germany Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 37. Germany Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 38. Germany Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 39. France Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 41. France Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 42. France Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 43. France Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 44. Italy Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 46. Italy Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 47. Italy Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 48. Italy Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 49. United Kingdom Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 51. United Kingdom Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 52. United Kingdom Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 53. United Kingdom Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 54. Russia Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 56. Russia Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 57. Russia Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 58. Russia Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 59. Netherlands Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 61. Netherlands Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 62. Netherlands Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 63. Netherlands Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 64. Spain Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 66. Spain Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 67. Spain Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 68. Spain Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 69. Turkey Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 71. Turkey Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 72. Turkey Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 73. Turkey Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 74. Poland Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 76. Poland Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 77. Poland Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 78. Poland Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 79. South America Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 81. South America Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 82. South America Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 83. South America Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 84. South America Fertility Services Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 87. Brazil Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 88. Brazil Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 89. Brazil Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 90. Argentina Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 92. Argentina Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 93. Argentina Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 94. Argentina Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 95. Asia-Pacific Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 97. Asia-Pacific Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 98. Asia-Pacific Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 99. Asia-Pacific Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 100. Asia-Pacific Fertility Services Market Share (%), By Country, 2018-2032F
  • Figure 101. India Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 103. India Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 104. India Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 105. India Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 106. China Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 108. China Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 109. China Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 110. China Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 111. Japan Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 113. Japan Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 114. Japan Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 115. Japan Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 116. Australia Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 118. Australia Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 119. Australia Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 120. Australia Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 121. Vietnam Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 123. Vietnam Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 124. Vietnam Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 125. Vietnam Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 126. South Korea Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 128. South Korea Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 129. South Korea Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 130. South Korea Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 131. Indonesia Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 133. Indonesia Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 134. Indonesia Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 135. Indonesia Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 136. Philippines Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 138. Philippines Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 139. Philippines Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 140. Philippines Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 141. Middle East & Africa Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 143. Middle East & Africa Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 144. Middle East & Africa Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 145. Middle East & Africa Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 146. Middle East & Africa Fertility Services Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 149. Saudi Arabia Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 150. Saudi Arabia Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 151. Saudi Arabia Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 152. UAE Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 154. UAE Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 155. UAE Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 156. UAE Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 157. South Africa Fertility Services Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Fertility Services Market Share (%), By Procedure, 2018-2032F
  • Figure 159. South Africa Fertility Services Market Share (%), By Service, 2018-2032F
  • Figure 160. South Africa Fertility Services Market Share (%), By Cause of Infertility, 2018-2032F
  • Figure 161. South Africa Fertility Services Market Share (%), By Provider, 2018-2032F
  • Figure 162. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Service Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Cause of Infertility Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Provider Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024